MRI-Guided Procedure Software for Cancer

N/A

Waitlist Available

Led By David A Woodrum, M.D., Ph.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients already scheduled for a percutaneous MR guided procedure

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up will assess for 3 years with interval assessment each year

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing new software to see if it helps doctors place needles for biopsies and ablations.

Who is the study for?

This trial is for patients already scheduled to undergo MR-guided procedures like biopsies or ablations, where needles are inserted through the skin. Pregnant women cannot participate in this study.

What is being tested?

The study is evaluating new MRI imaging guidance software called Philips Interventional iSuite. It aims to see if this software can help doctors more accurately and quickly position needles during interventional procedures.

What are the potential side effects?

Since the trial involves standard MR-guided procedures with additional software guidance, side effects may not differ from typical risks of such interventions, which include discomfort at the needle insertion site and potential bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for an MRI-guided procedure that does not require surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ will assess for 3 years with interval assessment each year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~will assess for 3 years with interval assessment each year

This trial's timeline: 3 weeks for screening, Varies for treatment, and will assess for 3 years with interval assessment each year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Needle placement efficiency into target lesion

Secondary study objectives

Software ease of use in targeting lesion for treatment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: MRI guided procedure software evaluationExperimental Treatment1 Intervention

Evaluate the workflow and effectiveness of the Philips Interventional iSuite software during biopsies and/or ablations versus standard MR imaging in aiding needle placement.

0 / 1Eligibility criteria met